Sign In

Karen Lorenc

Vice President Strategic Program Direction, Hematology at Regeneron Pharmaceuticals, Inc.

Karen Rodriguez Lorenc is the Vice President of Strategic Program Direction in Hematology at Regeneron Pharmaceuticals, Inc., a role she has held since September 2020. In this position, she leads the strategic direction for hematology assets across various indications and phases of drug development. Her extensive background includes significant experience in clinical oncology and pharmaceutical development.

Professional Background

  • Current Role: Vice President, Global Program Head, Hematology and Translational Sciences at Regeneron Pharmaceuticals, Inc.
  • Previous Experience:
    • Executive Director, Global Program Clinical Head at Novartis (September 2018 - August 2020)
    • Senior Clinical Development Medical Director at Novartis (September 2014 - September 2018)
    • Various roles at Novartis including Franchise Head for Solid Tumors in Latin America and Medical Director for New Products Development.
    • Oncology and Hematology Medical Advisor at Quintiles.
    • Medical Oncologist at Hospital Aleman in Argentina.

Education

Karen holds a Master's degree in Clinical Effectiveness and is a certified clinical oncologist with a strong focus on hematology.

Her career reflects a commitment to advancing cancer treatment through innovative drug development and strategic leadership within the pharmaceutical industry.

Related Questions

What are Karen Lorenc's key achievements at Regeneron?
How did Karen Lorenc transition from clinical oncology to pharmaceutical leadership?
What specific programs is Karen Lorenc leading in hematology at Regeneron?
What is Karen Lorenc's educational background?
How has Karen Lorenc's role evolved at Regeneron since 2020?
Karen Lorenc
Add to my network

Location

United States